CLINUVEL PHARMACEUTICALS LIMITED (CUV)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

CUV - CLINUVEL PHARMACEUTICALS LIMITED

Year End: June
GICS Industry Group : Pharmaceuticals, Biotechnology & Life Sciences
Index: ASX200 | ASX300 | ALL-ORDS

Clinuvel is a biopharmaceutical company that develops and commercialises treatments for patients with genetic, metabolic and life threatening disorders. The company was founded and listed in 2001.

LAST PRICE CHANGE +/- CHANGE % VOLUME

$15.42

25 May
2022

-0.860

OPEN

$16.21

-5.28%

HIGH

$16.48

102,767

LOW

$15.41

OTHER COMPANIES IN THE SAME SECTOR
ACR . AHZ . CSL . IDT . IVX . MSB . MYX . RNO . OSL . TFC . TIS . KZA . AGH . FTT . PAR . ADO . PYC . RAC . RCE . ZNO . AVH . LGP . SPL . ARX . AFP . 1AD . TLX . PNV . MVP . BNO . NXS . GSS . EOF . NEU . PAL . PBP . BOT . IMU . MDC . IMM . PXS . HXL . MXC . OPT . ANP .
FNARENA'S MARKET CONSENSUS FORECASTS

- No Record -

Last ex-div: 02/09 - ex-div 2.5c (franking 0%)

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2022 FactSet UK Limited. All rights reserved
Title 201620172018201920202021
EPS Basic xxxxxxxxxxxxxxx50.1
DPS All xxxxxxxxxxxxxxx2.5
Sales/Revenue xxxxxxxxxxxxxxx48.0 M
Book Value Per Share xxxxxxxxxxxxxxx199.8
Net Operating Cash Flow xxxxxxxxxxxxxxx19.3 M
Net Profit Margin xxxxxxxxxxxxxxx51.54 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 201620172018201920202021
Return on Capital Employed xxxxxxxxxxxxxxx28.69 %
Return on Invested Capital xxxxxxxxxxxxxxx28.33 %
Return on Assets xxxxxxxxxxxxxxx26.01 %
Return on Equity xxxxxxxxxxxxxxx28.69 %
Return on Total Capital xxxxxxxxxxxxxxx30.50 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx17.2 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

This is work in progress. Bear with us. It'll be amazing.

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.0

No. Of Recommendations

0
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

CUV STOCK CHART